Search clinical trials for: TAK-117
Total 6298 results
-
TakedaCompletedHealthy Volunteers | Hepatic ImpairmentCzechia, Slovakia
-
TakedaCompleted
-
Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Basal Cell | Advanced Nonhematologic MalignanciesUnited States
-
TakedaTerminated
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Advanced Solid TumorsUnited States
-
TakedaCompleted
-
TakedaCompletedHealthy VolunteersUnited States
-
TakedaRecruitingRenal Impairment | Healthy VolunteersUnited States
-
TakedaCompleted
-
Millennium Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelofibrosis | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Myeloid Metaplasia | Philadelphia Chromosome-negative CML | Advanced PolycythemiaUnited States
-
TakedaCompletedBreast Neoplasm | Ovarian Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Renal NeoplasmUnited States
-
Calithera Biosciences, IncWithdrawnAdvanced Solid Neoplasms | Lymphoma Neoplasms
-
Santen Inc.CompletedPrimary Open-angle Glaucoma and Ocular HypertensionUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
University of California, San FranciscoNational Cancer Institute (NCI); Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Castration Levels of Testosterone | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
TakedaRecruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
TakedaRecruitingNarcolepsy Type 1 | Narcolepsy Type 2Spain, Germany, United States, Italy, Netherlands, Japan, France, Norway, Australia, Finland, Switzerland, Sweden
-
TakedaTakeda Development Center Americas, Inc.RecruitingUnresectable Locally Advanced or Metastatic CancerSpain, United States, Australia, Canada
-
TakedaTerminatedNeoplasms | Lymphoma | Hematologic NeoplasmsUnited States
-
TakedaActive, not recruiting
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
Calithera Biosciences, IncWithdrawnLymphoma, Malignant | Advanced Solid NeoplasmsUnited States
-
Calithera Biosciences, IncTerminatedLymphoma, Non-Hodgkin | Lymphoma, Follicular, Marginal ZoneKorea, Republic of, Japan
-
Calithera Biosciences, IncTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedNonhematologic Neoplasms, AdvancedJapan
-
TakedaCompletedHealthy VolunteersUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
TakedaCompletedErosive EsophagitisJapan
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
TakedaTerminatedDiabetic Neuropathies
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
TakedaCompletedDiabetes Mellitus, Type 2
-
Millennium Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
TakedaCompletedHealthy VolunteersUnited States
-
TakedaTerminatedLow TestosteroneUnited States
-
Columbia UniversityTerminatedBreast Cancer | Colon Cancer | NeuropathyUnited States
-
TakedaCompletedAutoimmune DiseaseUnited Kingdom
-
Presage BiosciencesTakedaCompleted
-
Millennium Pharmaceuticals, Inc.Completed
-
University College, LondonNot yet recruitingMedullary Thyroid Carcinoma | Bronchial and Thymic Neuroendocrine Tumour | Paraganglioma/ Phaeochromocytoma | Those Requiring Repeat Peptide Receptor Radionuclide Therapy
-
TakedaCompletedNarcolepsy Type 2Spain, United States, Japan, Italy, France, Germany, Australia, Netherlands, Finland, Norway, Sweden, Switzerland
-
TakedaCompletedHealthy Participants and Patients With NarcolepsyJapan
-
TakedaCompleted
-
TakedaOvid Therapeutics Inc.CompletedDevelopmental and/or Epileptic EncephalopathiesUnited States
-
TakedaCompletedDiabetic NeuropathiesUnited States, Canada